To include your compound in the COVID-19 Resource Center, submit it here.

Calculus of success

Calculus of success

This year is likely to shape up as the year of the deal, ranging from last-ditch desperation stands to true strategic partnerships. The latter, illustrated by last week's transaction between Cambridge NeuroScience Inc. and Boehringer Ingelheim GmbH, will point up the disparity between Wall Street's valuation of companies, and the value corporate partners are placing on technologies

Read the full 600 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers